Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Industry Growth Prospects Lie In Partnerships, Divestments

This article was originally published in The Tan Sheet

Executive Summary

The dynamic of large Rx pharma companies housing older OTC brands may be a significant limiting factor for future growth in the nonprescription drug market

You may also be interested in...

Consumer Shakeup: Procter & Gamble Swallows Gillette

Procter & Gamble's acquisition of Gillette extends the consumer product firm's dominance in the tooth-whitening category

Bristol Consumer Unit Suitors Tasked With Determining Value Of Excedrin

Bristol-Myers Squibb says it will contact potential buyers for its North American Consumer Medicines division "over the coming weeks.

Pfizer’s Listerine Comparisons To Floss Struck Down In NY Court

Listerine is not clinically proven to be as effective in fighting tooth and gum decay as flossing, a New York district judge ruled Jan. 6

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts